You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Board of Directors of BONESUPPORT HOLDING AB has applied for the company's shares to be admitted to trading on Nasdaq Stockholm's main market. Nasdaq Stockholm has approved the company's application subject to customary conditions. The objective is to broaden the shareholder base through a neAlready a subscriber Login You…
Alligator Bioscience has started trading of its shares on the main market of Nasdaq Stockholm. Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies and is pAlready a subscriber Login You have read all your free articles, to continue…
The Norwegian cancer vaccine company has raised NOK 370 million and entered the Oslo Stock Exchange on Monday 3 June 2019. Several interested parties have now become shareholders in the company, totalling approximately 1 500 shareholders, reports Oslo Cancer Cluster. “It is good for the NorwAlready a subscriber Login You…
Nasdaq Stockholm’s listing committee has decided that Xbrane Biopharma AB fulfills the requirements for admission to trading of the company’s shares on the main market Nasdaq Stockholm. The first day of trading of Xbrane’s shares on Nasdaq Stockholm is expected to be Monday 23 September 201Already a subscriber Login You…
